EUVIMEDEUVIMED entdecken
Open Access

COVID ‐19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T‐cells

Rebecca S Parker, Justin Le, Miguel Villa, Annie Luong, Tsen Yin Lin, Yesun Lee, Andrew Doan, Paibel Aguayo-Hiraldo, Pia S Pannaraj, Seon-Jae Yoon, William Dean Wallace, April Armstrong und 3 weitere

International Journal of Cancer · 2024

DOI: 10.1002/ijc.35096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Rebecca S Parker und 14 weiteren Autor:innen. Beteiligte Einrichtung: Children's Center for Cancer and Blood Disease, Children's Hospital Los Angeles, California, Los Angeles, USA. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, COVID-19, COVID-19 Vaccines, Antibodies, Viral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: W. M. Keck Foundation, Malibu Triathlon Foundation, Children's Cancer Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Little is known about the efficacy of COVID‐19 vaccines during acute lymphoblastic leukemia therapy (ALL); data for COVID‐19 vaccine immune responses in pediatric leukemia remain sparse. We conducted a single center study of patients aged 5–25 years undergoing ALL chemotherapy who received COVID‐19 vaccination. Twenty‐one patients were enrolled; efficacy was evaluable in 20. Twenty were vaccinated while receiving chemotherapy. Twenty received the BNT162b2 mRNA vaccine. Spike reactive antibodies (S‐IgG) and/or T‐cells (SRT) were detected in 16 of 20 (80%) vaccinated patients; 13 (65%) and 9 (45%) were positive for S‐IgG and SRT, respectively. Six (30%) showed both spike reactive B and T‐cell responses. Eleven of the 13 with S‐IgG positivity were negative for anti‐Nucleocapsid IgG, an antibody profile consistent with a vaccine induced immune response. All 13S‐IgG+ patients showed neutralizing antibodies. SRT included CD4+ (7) and CD8+ (6) T‐cells; both CD4+ and CD8+ SRT were seen in 4. SRT were multifunctional (producing multiple cytokines) in most patients (8 of 9); 4 showed SRT with triple cytokine and B‐cell co‐stimulatory responses, indicating a multimodal adaptive immune response. Immune responses were seen among patients vaccinated in the settings of lymphopenia (6 of 12) intensive chemotherapy (3 of 4), and Peg allergy (6 of 8). Sequencing revealed public CD4+ and CD8+ TCR sequences reactive to epitopes across the spike protein. In conclusion, COVID‐19 vaccination induced B and/or T‐cell responses in a majority of children and young adults undergoing ALL chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaCOVID-19COVID-19 VaccinesAntibodies, ViralSARS-CoV-2BNT162 VaccineHumansAdolescentChildMaleFemaleYoung AdultAdultChild, PreschoolSpike Glycoprotein, CoronavirusT-LymphocytesAntibodies, NeutralizingVaccinationImmunoglobulin G

Stichwörter der Autor:innen

COVID‐19 vaccineT‐cell responsepediatric ALL

Substanzen

COVID-19 VaccinesAntibodies, ViralBNT162 VaccineSpike Glycoprotein, CoronavirusAntibodies, Neutralizingspike protein, SARS-CoV-2Immunoglobulin G

Autor:innen und Institutionen

  • Children's Center for Cancer and Blood Disease, Children's Hospital Los Angeles, California, Los Angeles, USA.
  • The Saban Research institute, Children's Hospital Los Angeles, California, Los Angeles, USA.
  • Division of Infectious Diseases, Children's Hospital Los Angeles, California, Los Angeles, USA.
  • Department of Pediatrics, University of California San Diego, San Diego, California, USA.
  • Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Chintan Parekh

Förderung

  • W. M. Keck Foundation
  • Malibu Triathlon Foundation
  • Children's Cancer Research Fund
  • NIAID NIH HHS
  • Saban Research Institute
  • Concern Foundation
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Parker, R. S., Le, J., Villa, M., Luong, A., Lin, T. Y., Lee, Y., Doan, A., Aguayo-Hiraldo, P., Pannaraj, P. S., Yoon, S. J., Wallace, W. D., Armstrong, A., O'Gorman, M. R., Bard, J. D., & Parekh, C. (2024). COVID ‐19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T‐cells. International Journal of Cancer. https://doi.org/10.1002/ijc.35096

Vancouver

Parker RS, Le J, Villa M, Luong A, Lin TY, Lee Y, et al. COVID ‐19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T‐cells. International Journal of Cancer. 2024. doi:10.1002/ijc.35096

BibTeX
@article{Parker2024,
  author = {Parker, Rebecca S and Le, Justin and Villa, Miguel and Luong, Annie and Lin, Tsen Yin and Lee, Yesun and Doan, Andrew and Aguayo-Hiraldo, Paibel and Pannaraj, Pia S and Yoon, Seon-Jae and Wallace, William Dean and Armstrong, April and O'Gorman, Maurice R and Bard, Jennifer Dien and Parekh, Chintan},
  title = {COVID ‐19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T‐cells},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.35096}
}
Kostenlos starten →